HER-2 breast assay, linked to Herceptin, wins FDA's okay.

CAP today / College of American Pathologists

Volumn 12, Issue 10, 1998, Pages

  Graziano, C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; TRASTUZUMAB;

ARTICLE; BREAST TUMOR; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOHISTOCHEMISTRY; METHODOLOGY; SAFETY; STANDARD; UNITED STATES;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DEVICE APPROVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTOR, ERBB-2; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0032184864     PISSN: 08911525     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)